Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
At one large self-funded plan, provider shortages pushed more than 37% of the patients to get their behavioral health care ...
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
By Berkeley Lovelace Jr. The Biden administration on Friday released the next round of prescription drugs selected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback